Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma

This study has been completed.

Study NCT00060684 Information provided by Cell Therapeutics

First Received: May 9, 2003 Last Updated: September 18, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2007
Primary Completion Date:	January 2005 (Final data collection date for primary outcome measure)